Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) EBIAT (2016 - 2025)

Bio-Techne (TECH) has 17 years of EBIAT data on record, last reported at $38.0 million in Q4 2025.

  • For Q4 2025, EBIAT rose 8.94% year-over-year to $38.0 million; the TTM value through Dec 2025 reached $81.1 million, down 48.71%, while the annual FY2025 figure was $73.4 million, 56.34% down from the prior year.
  • EBIAT reached $38.0 million in Q4 2025 per TECH's latest filing, roughly flat from $38.2 million in the prior quarter.
  • Across five years, EBIAT topped out at $89.7 million in Q3 2022 and bottomed at -$17.7 million in Q2 2025.
  • Average EBIAT over 5 years is $46.3 million, with a median of $47.2 million recorded in 2021.
  • Peak YoY movement for EBIAT: skyrocketed 322.8% in 2022, then crashed 143.55% in 2025.
  • A 5-year view of EBIAT shows it stood at $72.1 million in 2021, then crashed by 30.61% to $50.0 million in 2022, then tumbled by 45.08% to $27.5 million in 2023, then increased by 27.03% to $34.9 million in 2024, then increased by 8.94% to $38.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were $38.0 million in Q4 2025, $38.2 million in Q3 2025, and -$17.7 million in Q2 2025.